Abstract
Prescription of anti-rheumatic drugs should be by approved name because in most cases differences in absorption can be compensated by titration of dosage against effectiveness and toxicity. There are a few instances, for example phenylbutazone, where known differences of bio-availability justify the use of a particular brand.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Davis S. S. Scientific principles in design of drug dosage formulations. Br Med J. 1972 Jan 8;1(5792):102–106. doi: 10.1136/bmj.1.5792.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GWILT J. R., ROBERTSON A., GOLDMAN L., BLANCHARD A. W. The absorption characteristics of paracetamol tablets in man. J Pharm Pharmacol. 1963 Jul;15:445–453. doi: 10.1111/j.2042-7158.1963.tb12812.x. [DOI] [PubMed] [Google Scholar]
- Searl R. O., Pernarowski M. The biopharmaceutical properties of solid dosage forms. I. An evaluation of 23 brands of phenylbutazone tablets. Can Med Assoc J. 1967 Jun 10;96(23):1513–1520. [PMC free article] [PubMed] [Google Scholar]